TRV-2026-0192Version 1 · Certified
Reason for this version
Certified into the record
Canonical text (the exact bytes fingerprinted)
TRUVACE RECORD VERSION record: TRV-2026-0192 version: 1 kind: certified reason: Certified into the record timestamp: 2026-07-13T21:33:57.207655Z status: published lens: trace sector: health headline: AI-driven multimodal retinal imaging for early detection and risk stratification of vascular and neurodegenerative diseases dek: Systemic vascular and neurodegenerative disorders are important causes of disability and death worldwide, mainly because of the late stage of diagnosis and the high cost of current screening tools. Artificial intelligence (AI) and multimodal retinal imaging offer a non-invasive and viable approach for early risk stratification and longitudinal monitoring. This review highlights how changes in the retinal vasculature and nerve layers are markers of underlying pathophysiologies related to cardiovascular, metabolic… gain_title: AI combined with multimodal retinal imaging provides a non-invasive method for early risk stratification and screening for cardiovascular, metabolic and neurodegenerative disorders using retinal vasculature and nerve layer changes. problem_title: AI-assisted retinal analysis faces implementation hurdles including lack of multicenter validation, need for prospective clinical trials, and unresolved data fusion and regulatory requirements. trace_subject: AI-assisted multimodal retinal imaging for early detection and risk stratification of systemic vascular and neurodegenerative diseases gain_reading: AI combined with multimodal retinal imaging provides a non-invasive method for early risk stratification and screening for cardiovascular, metabolic and neurodegenerative disorders using retinal vasculature and nerve layer changes. gain_evidence: Artificial intelligence (AI) and multimodal retinal imaging offer a non-invasive and viable approach for early risk stratification and longitudinal monitoring | AI-assisted retinal analysis may make way for early screening, better prevention, and more accessible precision healthcare problem_reading: AI-assisted retinal analysis faces implementation hurdles including lack of multicenter validation, need for prospective clinical trials, and unresolved data fusion and regulatory requirements. problem_evidence: there are still hurdles to be cleared, such as multicenter validation, prospective clinical trials, data fusion, and regulatory frameworks quick_read: A May 2026 review in Graefe's Archive describes AI combined with multimodal retinal imaging as a non-invasive approach to detect and monitor systemic vascular and neurodegenerative conditions. It outlines how fundus photography, OCT, OCTA and metabolic-sensitive imaging capture retinal vascular and nerve changes that reflect cardiovascular, metabolic and neurological disease, analyzed with deep learning and multimodal fusion. The potential impact is earlier, lower-cost screening and longitudinal monitoring for conditions ranging from hypertension and coronary artery disease to Alzheimer's and Parkinson's, potentially improving prevention and precision healthcare access. Real-world adoption remains uncertain because the source notes unresolved needs for multicenter validation, prospective trials, data fusion methods and regulatory frameworks. limitation: Clinical translation is limited by need for multicenter validation, prospective trials, data fusion challenges and regulatory frameworks. tag: Automated dual reading key_points: Retinal vasculature and nerve layer changes are described as markers of underlying pathophysiologies for cardiovascular, metabolic and neurological disorders. | Review covers imaging modalities including fundus photography, optical coherence tomography (OCT), OCT angiography (OCTA), and metabolic-sensitive imaging. | AI approaches discussed include deep learning, self-supervised learning, and multimodal fusion for risk stratification and decision support. | Conditions cited with evidence include hypertension, stroke, coronary artery disease, diabetic complications, Alzheimer's, Parkinson's, multiple sclerosis and cognitive impairment. rundown: The review details how fundus photography, OCT, OCTA and newer metabolic-sensitive modalities capture vascular and neural retinal changes linked to systemic disease. It describes AI methods such as deep learning, self-supervised learning and multimodal fusion being leveraged for better risk stratification and decision support. Evidence is summarized across hypertension, stroke, coronary artery disease, diabetic complications, Alzheimer's disease, Parkinson's disease, multiple sclerosis and cognitive impairment to support the retina as a scalable biomarker. The authors note systemic disorders cause disability and death due to late diagnosis and high screening costs, positioning AI retinal analysis as a more accessible alternative pending validation. sources: - peer_reviewed | Graefe's Archive for Clinical and Experimental Ophthalmology | https://doi.org/10.1007/s00417-026-07273-6 | 2026-05-22 prev: 0000000000000000000000000000000000000000000000000000000000000000
- sha256
- 960b16fb94aa7d0eee3fa21f60310ed77fd517bf414b2cda73878c4b65bdf72a
- previous
- 0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0192 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace